Causes and consequences of DNA hypomethylation in human cancer.
暂无分享,去创建一个
[1] P. Deininger,et al. Inviting instability: Transposable elements, double-strand breaks, and the maintenance of genome integrity. , 2007, Mutation research.
[2] P. Molloy,et al. DNA hypomethylation and human diseases. , 2007, Biochimica et biophysica acta.
[3] W. Schulz,et al. Epigenetic control of CTCFL/BORIS and OCT4 expression in urogenital malignancies. , 2006, Biochemical pharmacology.
[4] Kentaro Yamashita,et al. Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. , 2006, Cancer cell.
[5] W. Schulz. L1 Retrotransposons in Human Cancers , 2006, Journal of biomedicine & biotechnology.
[6] W. Schulz,et al. Epigenetics of prostate cancer: beyond DNA methylation , 2006, Journal of cellular and molecular medicine.
[7] Peter A. Jones,et al. Epigenetic therapy of cancer: past, present and future , 2006, Nature Reviews Drug Discovery.
[8] W. Schulz,et al. Multiple mechanisms downregulate CDKN1C in human bladder cancer , 2005, International journal of cancer.
[9] M. Arcasoy,et al. Erythropoietin and erythropoietin receptor expression in human prostate cancer , 2005, Modern Pathology.
[10] S. Klimašauskas,et al. Processive Methylation of Hemimethylated CpG Sites by Mouse Dnmt1 DNA Methyltransferase* , 2005, Journal of Biological Chemistry.
[11] T. Efferth,et al. Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell lines , 2005, Genes, chromosomes & cancer.
[12] Wolfgang A. Schulz,et al. Hypomethylation of the XIST gene promoter in prostate cancer. , 2005, Oncology research.
[13] A. Mégarbané,et al. Subcellular distribution of HP1 proteins is altered in ICF syndrome , 2005, European Journal of Human Genetics.
[14] M. Böttger,et al. High-mobility-group proteins and cancer—an emerging link , 2005, Journal of Cancer Research and Clinical Oncology.
[15] Li Yang,et al. Expression of Dnmt1, demethylase, MeCP2 and methylation of tumor-related genes in human gastric cancer. , 2004, World journal of gastroenterology.
[16] Apiwat Mutirangura,et al. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis , 2004, Oncogene.
[17] R. Paro,et al. Expression of leukemic MLL fusion proteins in Drosophila affects cell cycle control and chromosome morphology , 2004, Oncogene.
[18] R. Gillies,et al. Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.
[19] S. Toyooka,et al. Tumor‐specific exon creation of the HELLS/SMARCA6 gene in non‐small cell lung cancer , 2004, International journal of cancer.
[20] David Sidransky,et al. Genetic and Epigenetic screening for gene alterations of the chromatin‐remodeling factor, SMARCA4/BRG1, in lung tumors , 2004, Genes, chromosomes & cancer.
[21] W. Schulz,et al. Suppression of clonogenicity by mammalian Dnmt1 mediated by the PCNA-binding domain. , 2004, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[22] J. Hess. MLL: a histone methyltransferase disrupted in leukemia. , 2004, Trends in molecular medicine.
[23] R. Martienssen,et al. The role of RNA interference in heterochromatic silencing , 2004, Nature.
[24] W. Kaelin. The Von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer , 2004, Clinical Cancer Research.
[25] G. Hager,et al. Effects of chromatin structure on the enzymatic and DNA binding functions of DNA methyltransferases DNMT1 and Dnmt3a in vitro. , 2004, Biochemical and biophysical research communications.
[26] M. Widschwendter,et al. DNA hypomethylation is prevalent even in low-grade breast cancers , 2004, Cancer biology & therapy.
[27] T. Bestor,et al. Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L , 2004, Nature.
[28] E. Giovannucci. Alcohol, one-carbon metabolism, and colorectal cancer: recent insights from molecular studies. , 2004, The Journal of nutrition.
[29] S. Frede,et al. Hypoxia‐induced erythropoietin expression in human neuroblastoma requires a methylation free HIF‐1 binding site , 2004, Journal of cellular biochemistry.
[30] M. Fraga,et al. Human DNA Methyltransferase 1 Is Required for Maintenance of the Histone H3 Modification Pattern* , 2004, Journal of Biological Chemistry.
[31] M. Szyf,et al. DNA demethylation and cancer: therapeutic implications. , 2004, Cancer letters.
[32] R Engers,et al. Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation , 2004, British Journal of Cancer.
[33] Robert Brown,et al. Demethylation of DNA by decitabine in cancer chemotherapy , 2004, Expert review of anticancer therapy.
[34] Rolf Ohlsson,et al. The binding sites for the chromatin insulator protein CTCF map to DNA methylation-free domains genome-wide. , 2004, Genome research.
[35] Michael Black,et al. Role of transposable elements in heterochromatin and epigenetic control , 2004, Nature.
[36] D. S. Coffey,et al. High mobility group protein HMGI(Y) enhances tumor cell growth, invasion, and matrix metalloproteinase‐2 expression in prostate cancer cells , 2004, The Prostate.
[37] Jiang Xiao,et al. Biological functions of melanoma-associated antigens. , 2004, World journal of gastroenterology.
[38] K. Buetow,et al. Chromatin Remodeling Factors and BRM/BRG1 Expression as Prognostic Indicators in Non-Small Cell Lung Cancer , 2004, Clinical Cancer Research.
[39] Peter W. Laird,et al. DNA Hypomethylation and Ovarian Cancer Biology , 2004, Cancer Research.
[40] W. Herr,et al. Leukemia Proto-Oncoprotein MLL Forms a SET1-Like Histone Methyltransferase Complex with Menin To Regulate Hox Gene Expression , 2004, Molecular and Cellular Biology.
[41] G. Nicolson,et al. Expression of the metastasis‐associated MTA1 protein and its relationship to deacetylation of the histone H4 in esophageal squamous cell carcinomas , 2004, International journal of cancer.
[42] S. Tjulandin,et al. HERV‐K(HML‐2) GAG/ENV antibodies as indicator for therapy effect in patients with germ cell tumors , 2004, International journal of cancer.
[43] A. Jeltsch,et al. Chromatin Targeting of de Novo DNA Methyltransferases by the PWWP Domain* , 2004, Journal of Biological Chemistry.
[44] I. Leav,et al. Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis. , 2004, The American journal of pathology.
[45] Edith Heard,et al. Recent advances in X-chromosome inactivation. , 2004, Current opinion in cell biology.
[46] K. Schuebel,et al. CpG island hypermethylation is maintained in human colorectal cancer cells after RNAi-mediated depletion of DNMT1 , 2004, Nature Genetics.
[47] S. Clark,et al. Transcriptional Gene Silencing Promotes DNA Hypermethylation through a Sequential Change in Chromatin Modifications in Cancer Cells , 2004, Cancer Research.
[48] K. Robertson,et al. DNMT3B interacts with hSNF2H chromatin remodeling enzyme, HDACs 1 and 2, and components of the histone methylation system. , 2004, Biochemical and biophysical research communications.
[49] Jef D. Boeke,et al. Transcriptional disruption by the L1 retrotransposon and implications for mammalian transcriptomes , 2004, Nature.
[50] Y. Yatabe,et al. Maspin expression in normal lung and non-small-cell lung cancers: cellular property-associated expression under the control of promoter DNA methylation , 2004, Oncogene.
[51] S. Rabbani,et al. Demethylation of Urokinase Promoter as a Prognostic Marker in Patients with Breast Carcinoma , 2004, Clinical Cancer Research.
[52] J. Minna,et al. RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells. , 2004, Cancer research.
[53] S. Tognazzo,et al. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[54] Keith D Robertson,et al. Isolation and characterization of a novel DNA methyltransferase complex linking DNMT3B with components of the mitotic chromosome condensation machinery. , 2004, Nucleic acids research.
[55] A. Murrell,et al. Genomic Imprinting: CTCF Protects the Boundaries , 2004, Current Biology.
[56] Kenneth J. Chang,et al. Overexpression of metastatic tumor antigen 1 in hepatocellular carcinoma: Relationship to vascular invasion and estrogen receptor-alpha. , 2004, Human pathology.
[57] N. Brünner,et al. Tumor Tissue Levels of Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Marker in Primary Breast Cancer , 2004, Clinical Cancer Research.
[58] C. Hauser,et al. Changes in the Expression of Many Ets Family Transcription Factors and of Potential Target Genes in Normal Mammary Tissue and Tumors* , 2004, Journal of Biological Chemistry.
[59] H. Kazazian. Mobile Elements: Drivers of Genome Evolution , 2004, Science.
[60] Michael Goggins,et al. Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling , 2004, Oncogene.
[61] S. Nishizuka,et al. Demethylation of MAGE promoters during gastric cancer progression , 2004, British Journal of Cancer.
[62] A. D. De Marzo,et al. GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer , 2004, Journal of cellular biochemistry.
[63] M. Vairapandi. Characterization of DNA demethylation in normal and cancerous cell lines and the regulatory role of cell cycle proteins in human DNA demethylase activity , 2004, Journal of cellular biochemistry.
[64] Kazuyoshi Saito,et al. Disruption of cell-type-specific methylation at the Maspin gene promoter is frequently involved in undifferentiated thyroid cancers , 2004, Oncogene.
[65] Kairong Cui,et al. BRG1 Controls the Activity of the Retinoblastoma Protein via Regulation of p21CIP1/WAF1/SDI , 2004, Molecular and Cellular Biology.
[66] A. El-Osta. The rise and fall of genomic methylation in cancer , 2004, Leukemia.
[67] J. Issa,et al. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. , 2004, Nucleic acids research.
[68] S. Varambally,et al. The Role of Metastasis-Associated Protein 1 in Prostate Cancer Progression , 2004, Cancer Research.
[69] D. Denhardt,et al. Tissue inhibitor of metalloproteinase-1 stimulates proliferation of human cancer cells by inhibiting a metalloproteinase , 2004, British Journal of Cancer.
[70] O. Ogawa,et al. XISTunmethylated DNA fragments in male-derived plasma as a tumour marker for testicular cancer , 2004, The Lancet.
[71] A. Harris,et al. Hypoxia-inducible factors and hypoxic cell death in tumour physiology , 2004, Annals of medicine.
[72] A. Kaneda,et al. Frequent hypomethylation in multiple promoter CpG islands is associated with global hypomethylation, but not with frequent promoter hypermethylation , 2004, Cancer science.
[73] E. Lees,et al. Role for BRG1 in Cell Cycle Control and Tumor Suppression , 2004, Molecular and Cellular Biology.
[74] R. Penzel,et al. CTCF Gene Mutations in Invasive Ductal Breast Cancer , 2003, Breast Cancer Research and Treatment.
[75] David I. K. Martin,et al. Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue , 2004, International Journal of Colorectal Disease.
[76] G. Nicolson,et al. Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: Role in epithelial cancer cell invasion, proliferation and nuclear regulation , 2004, Clinical & Experimental Metastasis.
[77] Stephen P. Fox,et al. Lsh, an epigenetic guardian of repetitive elements. , 2004, Nucleic acids research.
[78] C. V. Jongeneel,et al. Digital expression profiles of human endogenous retroviral families in normal and cancerous tissues. , 2004, Cancer immunity.
[79] M. Szyf. DNA methylation and cancer therapy. , 2005, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[80] J. McDonald,et al. L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas , 2004, Molecular Cancer.
[81] E. Ostertag,et al. SVA elements are nonautonomous retrotransposons that cause disease in humans. , 2003, American journal of human genetics.
[82] G. Watanabe,et al. The folate pool in colorectal cancers is associated with DNA hypermethylation and with a polymorphism in methylenetetrahydrofolate reductase. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[83] K. Choo,et al. Analysis of mammalian proteins involved in chromatin modification reveals new metaphase centromeric proteins and distinct chromosomal distribution patterns. , 2003, Human molecular genetics.
[84] C. Junien,et al. Silencing of CDKN1C (p57KIP2) is associated with hypomethylation at KvDMR1 in Beckwith–Wiedemann syndrome , 2003, Journal of medical genetics.
[85] T. Masuda,et al. Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells. , 2003, The American journal of pathology.
[86] Shirley M. Taylor,et al. p53-mediated repression of DNA methyltransferase 1 expression by specific DNA binding. , 2003, Cancer research.
[87] K. Muegge,et al. Lsh, a modulator of CpG methylation, is crucial for normal histone methylation , 2003, The EMBO journal.
[88] B. Richardson. DNA methylation and autoimmune disease. , 2003, Clinical immunology.
[89] Rakesh Kumar,et al. Emerging roles of MTA family members in human cancers. , 2003, Seminars in oncology.
[90] D. Fitzpatrick,et al. Methylation and demethylation in the regulation of genes, cells, and responses in the immune system. , 2003, Clinical immunology.
[91] M. Teitell,et al. DNA methylation in the immune system. , 2003, Clinical immunology.
[92] R. Hansen,et al. X inactivation-specific methylation of LINE-1 elements by DNMT3B: implications for the Lyon repeat hypothesis. , 2003, Human molecular genetics.
[93] I. Bièche,et al. Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[94] R. Claus,et al. Epigenetic targets in hematopoietic malignancies , 2003, Oncogene.
[95] J. Qin,et al. The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[96] A. Reeve,et al. Multipoint methylation analysis indicates a distinctive epigenetic phenotype among testicular germ cell tumors and testicular malignant lymphomas , 2003, Genes, chromosomes & cancer.
[97] S. Xiao,et al. Folic acid, polymorphism of methyl-group metabolism genes, and DNA methylation in relation to GI carcinogenesis , 2003, Journal of Gastroenterology.
[98] R. Weksberg,et al. Insulator and silencer sequences in the imprinted region of human chromosome 11p15.5. , 2003, Human molecular genetics.
[99] K. Muegge,et al. Lsh-deficient murine embryonal fibroblasts show reduced proliferation with signs of abnormal mitosis. , 2003, Cancer research.
[100] Hansoo Lee,et al. Promoter hypomethylation of a novel cancer/testis antigen gene CAGE is correlated with its aberrant expression and is seen in premalignant stage of gastric carcinoma. , 2003, Biochemical and biophysical research communications.
[101] C. Iacobuzio-Donahue,et al. Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. , 2003, Cancer research.
[102] J. Barrett,et al. DNA hypomethylation and imbalanced expression of DNA methyltransferases (DNMT1, 3A, and 3B) in human uterine leiomyoma. , 2003, Gynecologic oncology.
[103] En Li,et al. Suv 39 h-Mediated Histone H 3 Lysine 9 Methylation Directs DNA Methylation to Major Satellite Repeats at Pericentric Heterochromatin , 2003 .
[104] Satoshi Tanaka,et al. Transcription of mouse DNA methyltransferase 1 (Dnmt1) is regulated by both E2F-Rb-HDAC-dependent and -independent pathways. , 2003, Nucleic acids research.
[105] S. Sheng,et al. Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[106] W. Schulz,et al. Peculiar structure and location of 9p21 homozygous deletion breakpoints in human cancer cells , 2003, Genes, chromosomes & cancer.
[107] P. Vertino,et al. Effects of methylation on expression of TMS1/ASC in human breast cancer cells , 2003, Oncogene.
[108] S. Pradhan,et al. Allosteric activator domain of maintenance human DNA (cytosine-5) methyltransferase and its role in methylation spreading. , 2003, Biochemistry.
[109] W. Schulz,et al. Decrease of DNA methyltransferase 1 expression relative to cell proliferation in transitional cell carcinoma , 2003, International journal of cancer.
[110] K. Sugimachi,et al. The role of MTA1 gene expression in human hepatocellular carcinoma. , 2003, Oncology reports.
[111] T. Kouzarides,et al. The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. , 2003, Nucleic acids research.
[112] P. Pedersen,et al. Glucose Metabolism in Cancer , 2003, The Journal of Biological Chemistry.
[113] R. Jaenisch,et al. Chromosomal Instability and Tumors Promoted by DNA Hypomethylation , 2003, Science.
[114] Carlos S. Moreno,et al. MTA3, a Mi-2/NuRD Complex Subunit, Regulates an Invasive Growth Pathway in Breast Cancer , 2003, Cell.
[115] Rakesh Kumar. Another Tie that Binds the MTA Family to Breast Cancer , 2003, Cell.
[116] M. Ehrlich,et al. Expression of various genes is controlled by DNA methylation during mammalian development , 2003, Journal of cellular biochemistry.
[117] P. Laird. Early detection: The power and the promise of DNA methylation markers , 2003, Nature Reviews Cancer.
[118] G. V. van Muijen,et al. Cancer/testis‐associated genes: Identification, expression profile, and putative function , 2003, Journal of cellular physiology.
[119] M. Ladanyi,et al. Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site. , 2003, Human molecular genetics.
[120] A. Godwin,et al. Hypomethylation of the Synuclein γ Gene CpG Island Promotes Its Aberrant Expression in Breast Carcinoma and Ovarian Carcinoma , 2003 .
[121] S. Tilghman,et al. A differentially methylated region within the gene Kcnq1 functions as an imprinted promoter and silencer. , 2003, Human molecular genetics.
[122] S. Rowland-Jones,et al. Demystified . . . Human endogenous retroviruses , 2003, Molecular pathology : MP.
[123] R. Seruca,et al. Role of site-specific promoter hypomethylation in aberrant MUC2 mucin expression in mucinous gastric carcinomas. , 2003, Cancer letters.
[124] K. Almholt,et al. Stromal cell involvement in cancer. , 2003, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[125] A. Feinberg,et al. Epigenetic variability and the evolution of human cancer. , 2003, Advances in cancer research.
[126] D. Gisselsson. Chromosome instability in cancer: how, when, and why? , 2003, Advances in cancer research.
[127] C. Steinhoff,et al. Transcriptional regulation of the human LINE-1 retrotransposon L1.2B , 2003, Molecular Genetics and Genomics.
[128] M. Robert,et al. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells , 2003, Nature Genetics.
[129] M. Szyf,et al. Human DNA methyltransferase gene DNMT1 is regulated by the APC pathway. , 2003, Carcinogenesis.
[130] B. Migeon. X chromosome inactivation: theme and variations , 2003, Cytogenetic and Genome Research.
[131] A. Feinberg,et al. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. , 2002, Cancer research.
[132] P. Vertino,et al. DNMT1 is a Component of a Multiprotein DNA Replication Complex , 2002, Cell cycle.
[133] A. Feinberg,et al. DNA methylation and genomic imprinting: insights from cancer into epigenetic mechanisms. , 2002, Seminars in cancer biology.
[134] Victor V Lobanenkov,et al. The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer. , 2002, Seminars in cancer biology.
[135] P. Laird,et al. Hypomethylation and hypermethylation of DNA in Wilms tumors , 2002, Oncogene.
[136] T. Visakorpi,et al. Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma , 2002, Genes, chromosomes & cancer.
[137] E. Li. Chromatin modification and epigenetic reprogramming in mammalian development , 2002, Nature Reviews Genetics.
[138] M. Ehrlich,et al. DNA methylation in cancer: too much, but also too little , 2002, Oncogene.
[139] M. Turker. Gene silencing in mammalian cells and the spread of DNA methylation , 2002, Oncogene.
[140] K. Robertson. DNA methylation and chromatin – unraveling the tangled web , 2002, Oncogene.
[141] M. Kuwano,et al. The association of death-associated protein kinase hypermethylation with early recurrence in superficial bladder cancers. , 2002, Cancer research.
[142] T. Kouzarides,et al. DNA methyltransferases get connected to chromatin. , 2002, Trends in genetics : TIG.
[143] S. Kishikawa,et al. Regulation of transcription of the Dnmt1 gene by Sp1 and Sp3 zinc finger proteins. , 2002, European journal of biochemistry.
[144] Peter A. Jones,et al. The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.
[145] S. Galande. Chromatin (dis)organization and cancer: BUR-binding proteins as biomarkers for cancer. , 2002, Current cancer drug targets.
[146] C. Plass,et al. Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors , 2002, Oncogene.
[147] Hong Duan,et al. Role for DNA methylation in the control of cell type–specific maspin expression , 2002, Nature Genetics.
[148] C. Kanduri,et al. A Differentially Methylated Imprinting Control Region within the Kcnq1 Locus Harbors a Methylation-sensitive Chromatin Insulator* , 2002, The Journal of Biological Chemistry.
[149] J. J. Breen,et al. BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[150] H. Hausen. Papillomaviruses and cancer: from basic studies to clinical application , 2002, Nature Reviews Cancer.
[151] A. Veronese,et al. Loss of methylation at chromosome 11p15.5 is common in human adult tumors. , 2002 .
[152] Bert Vogelstein,et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells , 2002, Nature.
[153] Robert Brown,et al. Epigenomics and epigenetic therapy of cancer. , 2002, Trends in molecular medicine.
[154] R. Dahiya,et al. DNA methyltransferase and demethylase in human prostate cancer , 2002, Molecular carcinogenesis.
[155] S. Pradhan,et al. The retinoblastoma gene product interacts with maintenance human DNA (cytosine‐5) methyltransferase and modulates its activity , 2002, The EMBO journal.
[156] S. Minucci,et al. Methyltransferase Recruitment and DNA Hypermethylation of Target Promoters by an Oncogenic Transcription Factor , 2002, Science.
[157] S. Clark,et al. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells , 2002, Oncogene.
[158] W. Isaacs,et al. High mobility group protein I(Y): a candidate architectural protein for chromosomal rearrangements in prostate cancer cells. , 2002, Cancer research.
[159] C. Hsieh,et al. Murine De Novo Methyltransferase Dnmt3a Demonstrates Strand Asymmetry and Site Preference in the Methylation of DNA In Vitro , 2002, Molecular and Cellular Biology.
[160] H. Sasaki,et al. Expression of the MTA1 mRNA in advanced lung cancer. , 2002, Lung cancer.
[161] Gangning Liang,et al. Cooperativity between DNA Methyltransferases in the Maintenance Methylation of Repetitive Elements , 2002, Molecular and Cellular Biology.
[162] K. Robertson,et al. Chromatin remodeling, histone modifications, and DNA methylation—how does it all fit together? , 2002, Journal of cellular biochemistry.
[163] J. Cameron,et al. Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. , 2002, The American journal of pathology.
[164] Wen-Hwa Lee,et al. Retinoblastoma tumor suppressor and genome stability. , 2002, Advances in cancer research.
[165] S. Piantadosi,et al. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide. , 2001, Cancer research.
[166] J. Minna,et al. Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. , 2001, Cancer research.
[167] Jeannie T. Lee,et al. CTCF, a Candidate Trans-Acting Factor for X-Inactivation Choice , 2001, Science.
[168] E. Ostertag,et al. Biology of mammalian L1 retrotransposons. , 2001, Annual review of genetics.
[169] K. Muegge,et al. Lsh, a member of the SNF2 family, is required for genome-wide methylation. , 2001, Genes & development.
[170] E. Selker,et al. A histone H3 methyltransferase controls DNA methylation in Neurospora crassa , 2001, Nature.
[171] Karl Mechtler,et al. Loss of the Suv39h Histone Methyltransferases Impairs Mammalian Heterochromatin and Genome Stability , 2001, Cell.
[172] W. Hong,et al. Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis. , 2001, Cancer research.
[173] D. Takai,et al. Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer. , 2001, Human molecular genetics.
[174] N. Zingler,et al. Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription. , 2001, Nucleic acids research.
[175] S. Baylin,et al. Dnmt3a and Dnmt3b Are Transcriptional Repressors That Exhibit Unique Localization Properties to Heterochromatin* , 2001, The Journal of Biological Chemistry.
[176] W. Lau,et al. Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma. , 2001, The American journal of pathology.
[177] S. Saga,et al. Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma , 2001, British Journal of Cancer.
[178] C. Yue,et al. Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene , 2001, Oncogene.
[179] A. Lobuglio,et al. Expression of Human Endogenous Retrovirus K Envelope Transcripts in Human Breast Cancer 1 , 2001 .
[180] A. Harel-Bellan,et al. The Rb/chromatin connection and epigenetic control: opinion , 2001, Oncogene.
[181] Keith D Robertson,et al. DNA methylation, methyltransferases, and cancer , 2001, Oncogene.
[182] T. Kouzarides,et al. Dnmt3a binds deacetylases and is recruited by a sequence‐specific repressor to silence transcription , 2001, The EMBO journal.
[183] M. Szyf,et al. A novel regulatory element in the dnmt1 gene that responds to co-activation by Rb and c-Jun. , 2001, Gene.
[184] M. Szyf. The role of DNA methyltransferase 1 in growth control. , 2001, Frontiers in bioscience : a journal and virtual library.
[185] H Ishii,et al. Expression of mRNA for DNA methyltransferases and methyl‐CpG–binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis , 2001, Hepatology.
[186] K. Akashi,et al. Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. , 2001, Blood.
[187] S. Tajima,et al. Proliferation stage-dependent expression of DNA methyltransferase (Dnmt1) in mouse small intestine. , 2001, Cell structure and function.
[188] J. V. Moran,et al. Initial sequencing and analysis of the human genome. , 2001, Nature.
[189] S. Hirohashi,et al. DNA methyltransferase expression and DNA methylation of CPG islands and peri‐centromeric satellite regions in human colorectal and stomach cancers , 2001, International journal of cancer.
[190] Matthew Tudor,et al. Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation , 2001, Nature Genetics.
[191] Y. Kim,et al. Methylenetetrahydrofolate Reductase Polymorphisms, Folate, and Cancer Risk: a Paradigm of Gene-Nutrient Interactions in Carcinogenesis , 2009 .
[192] U. Kees,et al. Promoter demethylation accompanies reactivation of the HOX11 proto‐oncogene in leukemia , 2000, Genes, chromosomes & cancer.
[193] O. Yamazaki,et al. Erythrocytosis caused by an erythropoietin‐producing hepatocellular carcinoma , 2000, Journal of surgical oncology.
[194] R. Reinhardt,et al. Sequence and functional comparison in the Beckwith-Wiedemann region: implications for a novel imprinting centre and extended imprinting. , 2000, Human molecular genetics.
[195] W. Schulz,et al. DNA Methylation and the Mechanisms of CDKN2A Inactivation in Transitional Cell Carcinoma of the Urinary Bladder , 2000, Laboratory Investigation.
[196] T. Bestor,et al. The DNA methyltransferases of mammals. , 2000, Human molecular genetics.
[197] I. Pogribny,et al. Increase in Plasma Homocysteine Associated with Parallel Increases in Plasma S-Adenosylhomocysteine and Lymphocyte DNA Hypomethylation* , 2000, The Journal of Biological Chemistry.
[198] D. Zink,et al. Chromodomains are protein–RNA interaction modules , 2000, Nature.
[199] D. Takai,et al. Hypomethylation of LINE1 retrotransposon in human hepatocellular carcinomas, but not in surrounding liver cirrhosis. , 2000, Japanese journal of clinical oncology.
[200] F. Soussaline,et al. A CpG-rich RNA and an RNA helicase tightly associated with the DNA demethylation complex are present mainly in dividing chick embryo cells. , 2000, European journal of cell biology.
[201] Peter L. Jones,et al. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters , 2000, Nature Genetics.
[202] M. Ehrlich,et al. DNA hypomethylation and unusual chromosome instability in cell lines fromICF syndrome patients , 2000, Cytogenetic and Genome Research.
[203] Y. Atomi,et al. Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins. , 2000, Cancer research.
[204] K. Robertson,et al. Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1, 3a and 3b during the G(0)/G(1) to S phase transition in normal and tumor cells. , 2000, Nucleic acids research.
[205] C. Croce,et al. Gain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[206] J. Herman,et al. CpG methylation is maintained in human cancer cells lacking DNMT1 , 2000, Nature.
[207] D. Higgs,et al. Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation , 2000, Nature Genetics.
[208] M. Hendrix,et al. Epigenetic silencing of maspin gene expression in human breast cancers , 2000, International journal of cancer.
[209] J. Herman,et al. Methylation Patterns of the E-cadherin 5′ CpG Island Are Unstable and Reflect the Dynamic, Heterogeneous Loss of E-cadherin Expression during Metastatic Progression* , 2000, The Journal of Biological Chemistry.
[210] G. Liang,et al. Relationship between transcription and DNA methylation. , 2000, Current topics in microbiology and immunology.
[211] L. Shaffer,et al. Molecular mechanisms for constitutional chromosomal rearrangements in humans. , 2000, Annual review of genetics.
[212] K. Blanchard,et al. DNA methylation represses the expression of the human erythropoietin gene by two different mechanisms. , 2000, Blood.
[213] C. Wijmenga,et al. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[214] C. Hsieh. In Vivo Activity of Murine De Novo Methyltransferases, Dnmt3a and Dnmt3b , 1999, Molecular and Cellular Biology.
[215] R. Lupu,et al. HMG-I(Y) recognizes base-unpairing regions of matrix attachment sequences and its increased expression is directly linked to metastatic breast cancer phenotype. , 1999, Cancer research.
[216] N. Tommerup,et al. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene , 1999, Nature.
[217] R. Jaenisch,et al. Mammalian (cytosine-5) methyltransferases cause genomic DNA methylation and lethality in Drosophila , 1999, Nature Genetics.
[218] Thierry Boon,et al. DNA Methylation Is the Primary Silencing Mechanism for a Set of Germ Line- and Tumor-Specific Genes with a CpG-Rich Promoter , 1999, Molecular and Cellular Biology.
[219] D. Haber,et al. DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development , 1999, Cell.
[220] S. Saga,et al. MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas , 1999, British Journal of Cancer.
[221] R. Löwer,et al. The pathogenic potential of endogenous retroviruses: facts and fantasies. , 1999, Trends in microbiology.
[222] A. Marzo,et al. Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis. , 1999, Cancer research.
[223] D. J. Driscoll,et al. A maternally methylated CpG island in KvLQT1 is associated with an antisense paternal transcript and loss of imprinting in Beckwith-Wiedemann syndrome. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[224] R. Löwer,et al. DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas , 1999, British Journal of Cancer.
[225] C. Croce,et al. Cancer-specific chromosome alterations in the constitutive fragile region FRA3B. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[226] W. Schulz,et al. High frequency of alterations in DNA methylation in adenocarcinoma of the prostate , 1999, The Prostate.
[227] P. Laird,et al. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. , 1999, Cancer research.
[228] Y. Atomi,et al. Determination of high mobility group I(Y) expression level in colorectal neoplasias: a potential diagnostic marker. , 1999, Cancer research.
[229] M. Ehrlich,et al. Frequent hypomethylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16. , 1999, Cancer genetics and cytogenetics.
[230] M. Ehrlich,et al. Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential. , 1999, Mutation research.
[231] T. Curran,et al. Role of DNA 5-methylcytosine transferase in cell transformation by fos. , 1999, Science.
[232] N. Tomilin. Control of genes by mammalian retroposons. , 1999, International review of cytology.
[233] K. Robertson,et al. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. , 1999, Nucleic acids research.
[234] K. Ohshima,et al. Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias. , 1998, Blood.
[235] C. Schmid,et al. Does SINE evolution preclude Alu function? , 1998, Nucleic acids research.
[236] S. Baylin,et al. Hypomethylation of pericentromeric DNA in breast adenocarcinomas , 1998, International journal of cancer.
[237] Rudolf Jaenisch,et al. DNA hypomethylation leads to elevated mutation rates , 1998, Nature.
[238] W. Schulz,et al. DNA methylation in urological malignancies (review). , 1998, International journal of oncology.
[239] M. Gassmann,et al. Oxygen-regulated erythropoietin gene expression is dependent on a CpG methylation-free hypoxia-inducible factor-1 DNA-binding site. , 1998, European journal of biochemistry.
[240] C. Deng,et al. Role of the ras-MAPK Signaling Pathway in the DNA Methyltransferase Response to DNA Hypomethylation , 1998, Biological chemistry.
[241] H. Ng,et al. Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1. , 1997, Science.
[242] T. Ørntoft,et al. Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. , 1997, Cancer research.
[243] M. Ehrlich,et al. DNA demethylation and pericentromeric rearrangements of chromosome 1. , 1997, Mutation research.
[244] Stephen B. Baylin,et al. Mapping Patterns of CpG Island Methylation in Normal and Neoplastic Cells Implicates Both Upstream and Downstream Regions inde Novo Methylation* , 1997, The Journal of Biological Chemistry.
[245] C. Walsh,et al. Cytosine methylation and the ecology of intragenomic parasites. , 1997, Trends in genetics : TIG.
[246] W. Reik,et al. Imprinting in clusters: lessons from Beckwith-Wiedemann syndrome. , 1997, Trends in genetics : TIG.
[247] R. Sager,et al. Expression of maspin in prostate cells is regulated by a positive ets element and a negative hormonal responsive element site recognized by androgen receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[248] Y Lasne,et al. Involvement of DNA methylation in the control of the expression of an estrogen‐induced breast‐cancer‐associated protein (pS2) in human breast cancers , 1997, Journal of cellular biochemistry.
[249] M. Linsenmeyer,et al. Asymmetric Methylation in the Hypermethylated CpG Promoter Region of the Human L1 Retrotransposon* , 1997, The Journal of Biological Chemistry.
[250] A. Hochberg,et al. H19 in normal development and neoplasia , 1997, Molecular reproduction and development.
[251] W. Schulz,et al. Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma. , 1996, Cancer research.
[252] K. Roemer,et al. Regulation of human endogenous retrovirus-K Gag expression in teratocarcinoma cell lines and human tumours. , 1996, The Journal of general virology.
[253] A. Feinberg,et al. Limited up-regulation of DNA methyltransferase in human colon cancer reflecting increased cell proliferation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[254] A. Razin,et al. DNA Demethylation In Vitro: Involvement of RNA , 1996, Cell.
[255] L. Feng,et al. Chromosome 11p15.5 regional imprinting: comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors. , 1996, Human molecular genetics.
[256] H. G. van der Poel,et al. A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization. , 1996, British Journal of Cancer.
[257] B. Honoré,et al. Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. , 1996, The Journal of urology.
[258] R. Beart,et al. Mechanisms for the involvement of DNA methylation in colon carcinogenesis. , 1996, Cancer research.
[259] R. Ueda,et al. Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. , 1995, Oncogene.
[260] C. Schmid,et al. Alu repeated DNAs are differentially methylated in primate germ cells. , 1994, Nucleic acids research.
[261] D. Rigal,et al. Methylation patterns of long interspersed repeated DNA and alphoid repetitive DNA from human cell lines and tumors. , 1992, Anticancer research.
[262] Bratthauer Gl,et al. Active LINE-1 retrotransposons in human testicular cancer. , 1992 .
[263] M. Szyf,et al. Growth regulation of mouse DNA methyltransferase gene expression. , 1991, The Journal of biological chemistry.
[264] S. Baylin,et al. High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[265] H. Müller-Hermelink,et al. Intracellular distribution of DNA methyltransferase during the cell cycle , 1988, FEBS letters.
[266] A. Feinberg,et al. Reduced genomic 5-methylcytosine content in human colonic neoplasia. , 1988, Cancer research.
[267] P. V. van Helden,et al. Hypomethylation of DNA in pathological conditions of the human prostate. , 1987, Cancer research.
[268] A. Feinberg,et al. Hypomethylation of DNA from benign and malignant human colon neoplasms. , 1985, Science.
[269] R. Hoffman,et al. Altered methionine metabolism, DNA methylation and oncogene expression in carcinogenesis. A review and synthesis. , 1984, Biochimica et biophysica acta.
[270] J. Williams,et al. Biochemical strategy of hepatomas. , 1979, Journal of toxicology and environmental health.